Publication AbstractsWeight and balance--diet pills and flying.Borrillo DJ, Lozano D.Aviat Space Environ Med 1998; 69:11145. AbstractAuthorsÂ’ note: On September 15, 1997, the FDA, acting on evidence of "significant side-effects" associated with Dexfenfluramine (Redux©) and Fenfluramine (Pondimin©), requested the manufacturers of these products to voluntarily withdraw them for the treatment of obesity. The companies involved agreed to take them off the market. The FDA has not requested the withdrawal of Phentermine (Adipex©), another widely-used medication for obesity.
Information on subscribing, and on obtaining copies of an article or of an entire issue. Table of Contents for Volume 69, Number 11 of the ASEM journal.
|



